URL | https://www.thepharmaletter.com/pharmaceutical/tex |
Source | thepharmaletter.com |
Date Published | 09/24/2025 |
Company/Division name | Eli Lilly |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Year reshoring announced: | 2025 |
Year reshoring implemented or to be implemented: | 2030 |
Domestically, the work will be done: | In-house |
Capital investment ($): | 6500 |
City reshored to: | Houston |
State(s) reshored to: | TX |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | pharmaceuticals |